Atlas Trials

Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled

Clinical trial NCT02853578 · SUSPENDED

Trial details

NCT number
NCT02853578
Sponsor
Ache Laboratorios Farmaceuticos S.A.
Status
SUSPENDED
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2019-12-01
Primary completion
2020-10-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.